Cargando…

Staging esophageal cancer(1)

Accurate staging of disease is necessary in patients with newly diagnosed esophageal cancer in order to prompt appropriate curative or palliative therapy. Computed tomography (CT) may be used to evaluate for local spread into adjacent structures (T4 disease) and to diagnose distant metastases (M1)....

Descripción completa

Detalles Bibliográficos
Autores principales: Quint, Leslie Eisenbud, Bogot, Naama R.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582495/
https://www.ncbi.nlm.nih.gov/pubmed/18852079
http://dx.doi.org/10.1102/1470-7330.2008.9007
_version_ 1782160674131017728
author Quint, Leslie Eisenbud
Bogot, Naama R.
author_facet Quint, Leslie Eisenbud
Bogot, Naama R.
author_sort Quint, Leslie Eisenbud
collection PubMed
description Accurate staging of disease is necessary in patients with newly diagnosed esophageal cancer in order to prompt appropriate curative or palliative therapy. Computed tomography (CT) may be used to evaluate for local spread into adjacent structures (T4 disease) and to diagnose distant metastases (M1). Endoscopic ultrasonography (EUS) is the modality of choice for distinguishing T1 tumors from higher stage lesions and for detecting and sampling regional lymph nodes (N1 disease). Positron emission tomography (PET) scanning is most helpful for detecting previously occult distant metastases. Optimal staging generally requires a multimodality approach.
format Text
id pubmed-2582495
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-25824952010-10-04 Staging esophageal cancer(1) Quint, Leslie Eisenbud Bogot, Naama R. Cancer Imaging Focus on: Gastrointestinal Cancer Accurate staging of disease is necessary in patients with newly diagnosed esophageal cancer in order to prompt appropriate curative or palliative therapy. Computed tomography (CT) may be used to evaluate for local spread into adjacent structures (T4 disease) and to diagnose distant metastases (M1). Endoscopic ultrasonography (EUS) is the modality of choice for distinguishing T1 tumors from higher stage lesions and for detecting and sampling regional lymph nodes (N1 disease). Positron emission tomography (PET) scanning is most helpful for detecting previously occult distant metastases. Optimal staging generally requires a multimodality approach. e-Med 2008-10-04 /pmc/articles/PMC2582495/ /pubmed/18852079 http://dx.doi.org/10.1102/1470-7330.2008.9007 Text en © 2008 International Cancer Imaging Society
spellingShingle Focus on: Gastrointestinal Cancer
Quint, Leslie Eisenbud
Bogot, Naama R.
Staging esophageal cancer(1)
title Staging esophageal cancer(1)
title_full Staging esophageal cancer(1)
title_fullStr Staging esophageal cancer(1)
title_full_unstemmed Staging esophageal cancer(1)
title_short Staging esophageal cancer(1)
title_sort staging esophageal cancer(1)
topic Focus on: Gastrointestinal Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582495/
https://www.ncbi.nlm.nih.gov/pubmed/18852079
http://dx.doi.org/10.1102/1470-7330.2008.9007
work_keys_str_mv AT quintleslieeisenbud stagingesophagealcancer1
AT bogotnaamar stagingesophagealcancer1